共 11 条
[2]
Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO
[3]
2-F
[5]
THE RELATIVE TOXICITY OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
[J].
ARTHRITIS AND RHEUMATISM,
1993, 36 (03)
:297-306
[6]
Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases
[J].
IMMUNOPHARMACOLOGY,
2000, 47 (2-3)
:273-289
[7]
SAFETY AND EFFECTIVENESS OF LEFLUNOMIDE IN THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS - RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED, PHASE-II STUDY
[J].
ARTHRITIS AND RHEUMATISM,
1995, 38 (11)
:1595-1603
[10]
Weinblatt ME, 1999, ARTHRITIS RHEUM-US, V42, P1322, DOI 10.1002/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO